tiprankstipranks
Trending News
More News >
Standex International (SXI)
NYSE:SXI
Advertisement

Standex International (SXI) AI Stock Analysis

Compare
79 Followers

Top Page

SXI

Standex International

(NYSE:SXI)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
$261.00
▲(11.72% Upside)
Standex International's overall stock score is driven by strong earnings call performance and positive technical analysis. Financial performance is stable but shows room for improvement in profitability margins. The valuation is a concern due to a high P/E ratio, indicating potential overvaluation. The optimistic guidance and strategic expansions contribute positively to the outlook.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand and effective sales strategies, enhancing the company's market position and potential for future expansion.
New Product Sales
High growth in new product sales reflects successful innovation and market penetration, supporting long-term revenue streams and competitive advantage.
Operational Expansion
Expanding operations in strategic locations supports increased production capacity and market reach, fostering sustained growth and competitive positioning.
Negative Factors
Increased Net Debt
Rising net debt levels can strain financial flexibility and increase interest obligations, potentially impacting long-term financial health and investment capacity.
Profitability Pressure
Declining profit margins suggest challenges in cost management or pricing power, which could affect long-term profitability and shareholder returns.
Restructuring Charges
Restructuring costs indicate operational challenges and can lead to short-term financial strain, though they may offer long-term efficiency gains.

Standex International (SXI) vs. SPDR S&P 500 ETF (SPY)

Standex International Business Overview & Revenue Model

Company DescriptionStandex International Corporation, together with subsidiaries, manufactures and sells various products and services for commercial and industrial markets in the United States and internationally. It operates through five segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics segment offers reed relays, fluid level, proximity, motion, flow, HVAC condensate, and custom electronics sensors; and current sense and advanced planar transformer technologies, value added assemblies, and mechanical packaging, as well as custom wound transformers and inductors for low and high frequency applications. The Engraving segment provides mold texturizing, slush molding tools, roll engraving, hygiene product tooling, and low observation vents, as well as project management and design services for stealth aircraft; and process machinery for various industries. The Scientific segment offers temperature controlled equipment for the medical, scientific, pharmaceutical, biotech, and industrial markets. The Engineering Technologies segment offers net and near net formed single-source customized solutions that are used in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets. The Specialty Solutions segment manufactures and sells refrigerated, heated and dry merchandizing display cases, custom fluid pump solutions, single and double acting telescopic, and piston rod hydraulic cylinders. Standex International Corporation was founded in 1955 and is headquartered in Salem, New Hampshire.
How the Company Makes MoneyStandex International generates revenue through the sale of its diverse product offerings across its various business segments. The Food Service Equipment division is a significant contributor, providing solutions for commercial kitchens and food preparation, which includes cooking equipment and refrigeration systems. The Engineering Technologies segment focuses on custom-engineered products that cater to specific industrial needs, while the Electronics division manufactures components used in various electronic applications. The Hydraulics segment offers hydraulic solutions that serve both industrial and mobile markets. Standex also benefits from strategic partnerships with key players in its target industries, enhancing its market reach and enabling collaborative product development. Additionally, the company's commitment to research and development ensures a continuous stream of innovative products, further driving sales and revenue growth.

Standex International Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Jan 29, 2026
Earnings Call Sentiment Positive
The earnings call presented a strong performance in sales growth, particularly in new product sales and the Amran/Narayan Group. However, there were challenges such as organic declines in the Electronics and Scientific segments and restructuring costs. Despite these issues, the overall sentiment leans towards optimism with a positive sales outlook and strategic expansions.
Q1-2026 Updates
Positive Updates
Record Sales Growth
Sales increased 27.6% year-on-year to $217.4 million, with new product sales growing more than 35% to approximately $14.5 million. Orders reached approximately $226 million, marking the highest quarterly intake ever.
Strong Performance of Amran/Narayan Group
The Amran/Narayan Group delivered record sales of over $35 million and is expected to grow more than 20% year-on-year in fiscal 2026. Sales have grown nearly 35% over the past 12 months compared to before the acquisition.
Expanded Operations
New operations started in Croatia and Mexico, supporting growth in power requirements for data centers and grid expansion.
Increased Fiscal Year 2026 Sales Outlook
Revenue is now expected to grow by over $110 million, $10 million more than previously communicated, driven by strong momentum from new product sales and fast-growth markets.
Improved Adjusted Operating Margin
Adjusted operating margin increased 210 basis points year-on-year to 19.1%.
Negative Updates
Electronics Organic Decline
Electronics segment revenue showed an organic decline of 3.1% due to a facility closure and customer delays for alternate site approvals.
Scientific Segment Challenges
Scientific revenue faced an organic decline of 8.7% primarily due to lower demand from academic and research institutions impacted by NIH funding cuts.
Restructuring Charges
The Engraving segment announced the closure of 4 sites, resulting in approximately $5 million of restructuring charges, although expected to yield similar annualized cost savings.
Increased Net Debt
Standex had net debt of $446 million at the end of the fiscal first quarter 2026 compared to net cash of $15.6 million a year ago.
Company Guidance
During Standex International's fiscal first quarter 2026 conference call, the company provided an optimistic outlook, expecting fiscal year 2026 revenue to grow by over $110 million, an increase of $10 million from the previous guidance. This growth is driven by new product sales and fast-growth market sales, with the Amran/Narayan Group projected to grow over 20% year-on-year. Sales increased by 27.6% in the first quarter, with new product sales growing more than 35% to approximately $14.5 million. Orders hit a record high of approximately $226 million. Standex anticipates adjusted operating margin to be 19.1%, an increase of 210 basis points year-on-year. The company expects organic growth in its Electronics segment to reach mid- to high single-digits for fiscal 2026. Additionally, Standex celebrated the renaming of the Amran/Narayan Group to Standex Electronics Grid, reflecting its integration and success, with sales up nearly 35% in the past year.

Standex International Financial Statement Overview

Summary
Standex International demonstrates solid revenue growth and effective cost management, though profitability margins have seen some pressure. The balance sheet remains stable with moderate leverage, but there is room for improvement in return on equity. Cash flow generation is strong, with positive free cash flow growth, although operating cash flow efficiency could be enhanced. Overall, the company is on a stable financial footing with opportunities for further profitability improvements.
Income Statement
75
Positive
Standex International shows a solid revenue growth rate of 5.94% in the TTM, indicating positive sales momentum. The gross profit margin of 39.54% is healthy, reflecting effective cost management. However, the net profit margin has decreased to 6.29% from 7.06% in the previous annual report, suggesting pressure on profitability. The EBIT and EBITDA margins have also declined, indicating potential challenges in operational efficiency.
Balance Sheet
70
Positive
The company's debt-to-equity ratio of 0.82 in the TTM is moderate, suggesting a balanced approach to leverage. Return on equity stands at 8.22%, showing a slight improvement, but still below the industry average, indicating room for enhancing shareholder returns. The equity ratio of 45.52% reflects a stable financial structure, though slightly lower than previous periods.
Cash Flow
68
Positive
Free cash flow growth of 9.76% in the TTM is a positive sign, indicating improved cash generation. The operating cash flow to net income ratio of 0.41 suggests moderate cash conversion efficiency. The free cash flow to net income ratio of 0.97 indicates strong cash flow relative to earnings, although the operating cash flow has slightly decreased compared to previous periods.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue837.07M790.11M720.63M741.05M735.34M656.23M
Gross Profit330.96M300.64M282.00M285.10M269.95M241.26M
EBITDA127.27M128.18M121.92M191.45M116.63M91.98M
Net Income53.36M55.76M73.07M138.99M61.39M36.47M
Balance Sheet
Total Assets1.55B1.57B1.01B1.02B934.44M962.22M
Cash, Cash Equivalents and Short-Term Investments98.65M104.54M154.20M195.71M104.84M136.37M
Total Debt583.02M603.70M187.89M199.22M214.08M228.53M
Total Liabilities820.06M827.29M383.55M417.48M435.10M455.80M
Stockholders Equity707.66M711.68M621.50M607.45M499.34M506.43M
Cash Flow
Free Cash Flow60.59M41.25M72.36M66.53M53.83M61.83M
Operating Cash Flow68.87M69.60M92.66M90.80M77.72M83.58M
Investing Cash Flow-503.48M-503.43M-61.63M41.56M-31.04M-39.09M
Financing Cash Flow371.27M380.49M-69.20M-40.04M-69.43M-31.73M

Standex International Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price233.63
Price Trends
50DMA
218.41
Positive
100DMA
196.28
Positive
200DMA
180.32
Positive
Market Momentum
MACD
5.25
Positive
RSI
54.31
Neutral
STOCH
52.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SXI, the sentiment is Neutral. The current price of 233.63 is below the 20-day moving average (MA) of 234.44, above the 50-day MA of 218.41, and above the 200-day MA of 180.32, indicating a neutral trend. The MACD of 5.25 indicates Positive momentum. The RSI at 54.31 is Neutral, neither overbought nor oversold. The STOCH value of 52.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SXI.

Standex International Risk Analysis

Standex International disclosed 26 risk factors in its most recent earnings report. Standex International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Standex International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$2.14B23.7422.47%0.10%4.65%8.81%
73
Outperform
$2.78B52.497.72%0.52%18.51%-28.69%
73
Outperform
$1.84B54.673.75%0.63%-1.46%-10.03%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
57
Neutral
$2.23B-1.50%2.85%-7.93%91.44%
55
Neutral
$3.18B-21.46%22.40%-18.99%
51
Neutral
$1.80B-2.13-28.31%14.40%-662.25%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SXI
Standex International
233.63
28.65
13.98%
EPAC
Enerpac Tool Group
41.19
-9.40
-18.58%
ENOV
Enovis
31.49
-16.37
-34.20%
HI
Hillenbrand
31.60
1.53
5.09%
HLIO
Helios Technologies
56.96
3.84
7.23%
XMTR
Xometry
62.67
32.07
104.80%

Standex International Corporate Events

Executive/Board ChangesShareholder Meetings
Standex International Holds Annual Stockholders Meeting
Neutral
Oct 31, 2025

Standex International held its Annual Meeting of Stockholders on October 21, 2025, with 11,304,234 common shares represented. During the meeting, stockholders voted to elect two directors, Thomas E. Chorman and Andy L. Nemeth, to three-year terms ending in 2028. Additionally, there was an advisory vote on executive compensation, which was approved, and the appointment of Deloitte & Touche, LLP as Independent Public Accountants for the fiscal year ending June 30, 2026, was ratified.

The most recent analyst rating on (SXI) stock is a Buy with a $260.00 price target. To see the full list of analyst forecasts on Standex International stock, see the SXI Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 03, 2025